Polaryx TherapeuticsPLYX
13F holders, Q1 2026 (March 31)14holders
1famous investor
$7.56avg. 13F price*
At the end of Q1 2026, 14 institutions reported holding Polaryx Therapeutics Inc. (PLYX) in their 13F filings. The largest holders were Vanguard Capital Management LLC ($12.5M), Geode Capital Management, LLC ($1.3M) and Millennium Management ($964K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Polaryx Therapeutics Inc.
- CUSIP
- 73110F100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $3.8M |
| Exits | 0 | $0 |
Ownership 14 holders
| Vanguard Capital Management LLC | 0.00% | — | 1,658,388 | $12.5M |
| Geode Capital Management, LLC | 0.00% | New | 170,673 | $1.3M |
| Millennium Management | 0.00% | New | 127,525 | $964K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 104,556 | $790K |
| State Street Corp. | 0.00% | New | 58,104 | $439K |
| BlackRock, Inc. | 0.00% | New | 41,012 | $310K |
| Northern Trust Corp. | 0.00% | New | 27,987 | $212K |
| Bank of America Corp. | 0.00% | New | 25,881 | $196K |
| Goldman Sachs Group Inc. | 0.00% | New | 13,483 | $102K |
| UBS Group AG | 0.00% | New | 13,479 | $102K |
| Squarepoint Ops LLC | 0.00% | New | 12,406 | $94K |
| Vanguard Global Advisers, LLC | 0.00% | — | 6,318 | $48K |
| Morgan Stanley | 0.00% | New | 5,543 | $42K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,781 | $13K |
"% of holder's portfolio" is PLYX's weight in each manager's 13F, not the share of Polaryx Therapeutics Inc. the manager owns.